二{氧合-二[2-呋喃甲酸二苄基锡(Ⅳ)]}的合成、性质及晶体结构

以二苄基氧化锡和2-呋喃基羧酸反应,合成了新的化合物二{氧合-二[2-呋喃甲酸二苄基锡(Ⅳ)]}.生物活性测试结果表明,该配合物具有较强的体外抗癌活性.X射线单晶衍射测定表明,配合物是以Sn2O2四元环为中心的、中心对称的二聚体结构,内环锡为六配位的畸变八面体结构,外环锡为五配位的加帽畸变三角双锥结构.     

梯形结构有机锡化合物二{氧合-二[2-吡啶甲酸二丁基锡(IV)]}的合成、性质和晶体结构

用二丁基氧化锡与 2 吡啶甲酸反应 ,合成了二 {氧合 -二 [2 吡啶甲酸二丁基锡 (IV) ] },并进行了元素分析、红外光谱、核磁共振锡谱表征 .X射线单晶衍射分析表明 ,化合物是以Sn2 O2 四面体为中心的 ,中心对称的二聚体结构 ,内环锡为五配位的畸变三角双锥构型 ,外环锡为六配位的畸变八面体结构 .生物活性测试结果表明 ,该配合物具有较强的体外抗癌活性 .     

基于酰腙配体的双锡核二(2,4-二氯苄基)锡配合物的合成、结构及生物活性

二(2,4-二氯苄基)二氯化锡分别与对甲氧基苯甲酰肼缩2-丁酮酸或2-噻吩酰肼缩2-丁酮酸酸反应,合成了两个二(2,4-二氯苄基)锡配合物(C1、C2),通过傅里叶变换红外光谱仪(FTIR)、核磁共振波谱仪(NMR)、高分辨质谱仪(HRMS)以及X射线单晶衍射(SCXRD)等表征了配合物结构。 两个配合物分子均为双锡核分子,以Sn₂O₂四元环为中心对称,且锡原子与配位原子形成七配位畸变五角双锥构型。 配合物C1、C2在空气氛围,120 ℃以下可稳定存在。 配合物C1、C2对人肺癌细胞(NCI-H460)、人肝癌细胞(HepG2)和人乳腺癌细胞(MCF7)均有较好的抑制作用,配合物C1略优于C2。 配合物C1、C2通过插入结合方式与小牛胸腺DNA相互作用,并且配合物C1与DNA的作用略强于C2。     

两个有机锡杂环羧酸酯配合物的合成、结构及抗癌活性

合成了2个有机锡杂环羧酸酯配合物：二（邻溴苄基）锡二（2-吡啶甲酸）酯（1）和三（2-甲基-2-苯基丙基）锡3-吲哚丁酸酯（2）。通过元素分析、红外光谱、核磁共振谱（¹H、¹³C和¹¹⁹Sn）、X射线衍射、热重分析进行了表征,用X射线单晶衍射方法测定了配合物的晶体结构,进行了配合物的结构量子化学从头计算和体外抗癌活性研究。结果显示：配合物均为单锡核分子,锡原子分别为六配位的畸变八面体构型和四配位的畸变四面体构型;配合物对人肝癌细胞（HUH7）、人肺癌细胞（A549）、人表皮癌细胞（A431）、人结肠癌细胞（HCT-116）和乳腺癌细胞（MDA-MB-231）的抑制活性均比临床使用的顺铂强。     

二烃基锡二茂铁羧酸酯的合成及研究

通过二烃基氧化锡与取代二茂铁羧酸缩合，合成14个末见文献报道的二烃基锡 二茂铁羧酸酯化合物．通过对化合物的核磁共振谱、红外光谱、元素分析的研究， 确定化合物的组成和结构及形成结构的原因．化合物12的X衍射单晶测定表明，化 合物是以Sn2O2四元环为中心的中心对称二聚体结构、内环锡为5配位的畸变三角双 锥结构、外环锡为6配位的畸变八面体结构。化合物的抗癌活性实验结果表明，部 分化合物有较高的抗KB肿瘤细胞和抗Bel-7402肿瘤细胞活性．     

三(邻甲基苄基)锡和二(间氟苄基)锡硫代水杨酸酯配合物的合成、结构及性质

合成了三(邻甲基苄基)锡硫代水杨酸酯配合物(1)和一维链状二(间氟苄基)锡硫代水杨酸酯配合物(2),经元素分析、IR、NMR、X射线衍射等技术手段表征了其结构。配合物1属三斜晶系,空间群Pī,晶体学参数a=1.00221(5)nm,b=1.48934(8)nm,c=1.71789(9)nm,α=78.3120(10)°,β=85.6560(10)°,γ=80.2580(10)°,V=2.4725(2)nm~3,Z=2,Dc=1.371 g/cm~3,μ(Mo Kα)=10.91 cm~(-1),F(000)=1040,R_1=0.0439,wR_2=0.1119。配合物2属单斜晶系,空间群为P21/n,晶体学参数:a=1.17827(5)nm,b=2.11945(9)nm,c=1.55970(7)nm,β=93.4510(10)°,V=3.8880(3)nm~3,Z=4,Dc=1.671 g/cm~3,μ(Mo Kα)=14.53 cm~(-1),F(000)=1936,R1=0.0323,wR2=0.0927。配合物1中锡原子呈四配位畸变四面体构型,配合物2中锡原子呈五配位畸变三角双锥构型。配合物1和2分别在152和195℃下稳定,电化学性质不可逆,对人体癌细胞Colo205、Hep G2、MCF-7、Hela和NCI-H460具有体外抗癌活性,配合物2的抗癌活性远大于配合物1。     

一维链状二(3-氟苄基)锡二吡啶羧酸配合物的合成、结构及反应机理

一维链状二(3-氟苄基)锡二吡啶羧酸配合物的合成、结构及反应机理;有机锡配合物;吡啶甲酸;合成;晶体结构;生物活性;反应机理     

对氯苄基三苯基镌-马来二氰基二硫烯镍配合物的合成和晶体结构

合成了一种新的含取代苄基三苯基镌的马来二氰基二硫烯镍配合物[ClBzTPP]2[M（mnt）2]·H2O（[ClBzTPP]’代表对氯苄基三苯基锑阳离子,mnt^2-代表马来二氰基二硫烯阴离子）．配合物为三斜晶系,空间群Pi,晶胞参数为a=1．0585（2）nm,b=1．1089（2）nm,c=1．1570nm,α=81．98（1）°,β=84．95（1）°,γ=84．45（1）°,V=1．3691（4）nm^3,Z=1,最终一致性因子R=0．0584．该配合物由2个[ClBzT—PP]^＋阳离子,1个[M（mnt）2]^2-阴离子和1个H2O组成．其结构特点是配合物中的[C1BzTPP]’阳离子和Ni（mnt）2^2-阴离子沿c轴方向堆积成柱,并通过C—H…S,C—H…π,C—H…Ni氢键和π-π堆积作用形成了二维网状结构．     

含硫柔性二苯甲酸及氮杂环配体的Zn(Ⅱ)和Mn(Ⅱ)配合物的合成及晶体结构

以2,2′-二硫代二苯甲酸、2,2′-联吡啶、咪唑、硝酸锌和硝酸锰为原料,使用水热方法合成了配合物[Zn(EBLA)(2,2′-bipy)(H2O)](EBLA=2,2′-二苯甲酸硫醚)(2,2′-bipy=2,2′-联吡啶)(1),自然挥发法制备了配合物[Mn(EBSA)(im)2(H2O)]n(EBSA=2,2′-二硫代二苯甲酸)(im=咪唑)(2)。利用元素分析、红外和热重分析对其进行了表征。利用X-射线单晶衍射对结构进行了测定,并研究了配合物1的荧光性质。配合物1中,2,2′-二苯甲酸硫醚是通过水热方法由2,2′-二硫代二苯甲酸发生原位反应制备,Zn2+离子是五配位的四角锥双核结构;配合物2中,Mn2+离子是六配位的变形八面体一维链状结构。配合物中存在氢键和π-π堆积等弱的分子间作用力。     

杂环苄基锡氨基硫脲席夫碱配合物的合成与表征

二苄基二氯化锡和三苄基氯化锡分别与水杨醛缩氨基硫脲,含羟基芳香醛(酮)缩氨基硫脲的席夫碱钠盐反应,合成了10种新的有机锡配合物,其结构经1H NMR,119Sn NMR,IR和元素分析表征。结果表明,中心锡原子均为五配位杂单环结构。     

二聚体有机锡配合物{[n-Bu2Sn(O2CCH2CS2NC4H8)]2O}2的合成，表征及晶体结构(英)

The title compound, {[n-Bu₂Sn(O₂CCH₂CS₂NC₄H₈)]₂O}₂, has been synthesized by the reaction of (tetrahydro-pyrrodithiolocarbamoylthio)acetic acid with the di-n-bubyltin oxide in 1∶1 molar ratio. The complex has been characterized by elemental analysis, IR and NMR. The crystal structure of it has been determined by X-ray single crystal diffraction. And the results showed that the crystal belongs to triclinic system with space group P1 and some crystal parameters: a=1.220 2(9) nm, b=1.315 8(10) nm, c=1.380 4(10) nm, α=111.215(9)°， β=99.357(9)°， γ=96.075(10)°, V=2.006(2) nm³, Z=1, F(000)=908, μ=1.489 mm^-1, D_c=1.474 g·cm^-3, R₁=0.037 5, wR₂=0.0839. The complex has a centrosymmetric dimer structure mode with a four-membered central endo-cyclic Sn₂O₂ unit in which two bridged oxygen atoms both connect with an exo-cyclic tin atom which has a distorted octahedron. Each of the endo-cyclic tin atoms exhibits a distorted trigonal bipyramid coordination geometry with an additional weak coordination carboxylate oxygen. Four carboxylate ligands are divided into two types. And two of them are bidentate and connecting to each of exo-cyclic tin atoms by using both oxygen atoms, whereas the others bridge to each pair of exo-and endo-cyclic tin atoms utilizing one oxygen atom only. CCDC: 220513.     

有机锡配合物{[(n-C8H17)2Sn(O2CCH2CS2NC4H8O)]2O}2的合成，表征及晶体结构

The title complex {[(n-C₈H₁₇)₂Sn(O₂CCH₂CS₂NC₄H₈O)]₂O}₂ has been synthesized by the reaction of (morpholinylthiocarbamoylthio)acetic acid with the di-n-octyltin oxide in 1∶1 molar ratio. The complex was characterized by elemental analysis, IR and ¹H NMR. The crystal and molecular structure of complex was determined by X-ray single crystal diffraction. The crystal belongs to triclinic system with space group P1 and unit cell dimensions: a=1.201 5(9) nm, b=1.481 8(11) nm, c=1.894 1(14) nm, α=72.485(10)°, β=88.586(10)°, γ=66.893(9)°, and Z=1, μ=1.034 mm^-1, V=2.941(4) nm³, D_c=1.295 g·cm^-3, F(000)=1 196, R₁=0.058 8, wR₂=0.155 8. The complex is a centrosymmetric structure with a four-membered central endo-cyclic Sn₂O₂ unit in which two bridged oxygen atoms both connect with an exo-cyclic tin atom. The endo-cyclic tin atoms and the exo-cyclic tin atom are all five-coordinate and have coordination geometry of distorted trigonal bipyramid with an additional weak coordination carboxylate oxygen. Four carboxylate ligands are divided into two types. And two of them are monodentate and connecting to each of exo-cyclic tin atoms by using one oxygen atom, whereas the others bridge to each pair of exo-and endo-cyclic tin atoms utilizing one oxygen atom. CCDC: 277048.     

Synthesis,Characterization and Properties of Bis{oxo—bis[heteroaromatic carboxylatodibenzyltin（Ⅳ）]}and Crystal Structure of Bis{oxo—bis[2—furylcarboxylatodibenzyltin（Ⅳ）]}

IntroductionThe organotin( ) derivatives of carboxylicacids have been extensively studied due to their bio-logical activities[1— 4] . In recent years more andmore reports on the synthesis,antitumour activi-ties,biocidal activities,antibiotic activities andstructural elucidation of various organotin ( )derivatives of carboxylic acids have appeared[5— 10 ] .In particular,the diorganotin ( ) complexes ofcarboxylic acids have aroused a considerable inter-est of some scientists in the structur…     

μ3-O-{[μ-(n-Bu)2Sn(μ-FcCO2)(n-Bu)2Sn]FcCO2}二聚物的晶体结构和分子结构

标题配合物Ｍｒ＝９３３．８４,属单斜晶系,空间群Ｐ２_１／ｎ,晶胞参数ａ＝１５．２４４（４）Ａ,ｂ＝２０．８９５（７）Ａ,ｃ＝１２． ３７５（４）Ａ,β＝９７．３９（３）°,Ｚ＝４,Ｖ＝３９０９（２）Ａ~３,Ｄｃ＝１．５８７９·ｃｍ~（－３）,Ｆ（０００）＝１８７２,最终偏差因子Ｒ＝０．０６８４。该配合物分子呈中心对称,是具有Ｓｎ_２Ｏ_２中心内环的二聚体,Ｓｎ_２Ｏ_２中的每个桥氧原子又各连接一个外环锡而形成了四核分子。分子中四个羧酸酯基有桥联双齿（μ－ＣＯＯ）和单齿两种不同的配位模式;在内环锡和外环锡的配位单元中,锡均形成具有五配位的畸变三角双锥配位构型,同时另有一氧原子与中心锡原子之间有弱相互作用。它与类似物［ＦｃＣＯ_２Ｓｎ（ｎ－ＢＵ）_２］Ｏ｝_２·４Ｃ_６Ｈ_６的晶体结构完全不同,却又存在着内在的联系。     

二{氧合-二[3-二茂铁基丙烯酸二正丁基锡(Ⅳ)]} 配合物的晶体结构及溶液中的 配位互变平衡机理

测定了配合物{[(n-Bu)2Sn(FcCH=CHCO2)]2O}2(Fc=Ferrocenyl)晶体结构,它属三斜晶系,空间群P1,晶胞参数a=1.3943(3)nm,b=1.4635(3)m,c=1.2792(3)nm,α=94.32(3)°,β=116.27(3)°,γ=109.08(3)°,Z=2,V=2.1362(8)nm^3,Dc=1.542g/cm^3,F(000)=1004。最终偏差因子R=0.0401,Rw=0.1076。该分子中存在着内环锡和外环锡配位单元,锡原子均形成具有假六配位的单加帽畸变三角双锥配位构型。Sn2O2中心内环与丙烯酸酯基茂环等共轭体系之间相互未能共平面。配合物中四个羧基配体划分为两类：两个为桥式双齿配位(μ-COO),跨接于一个内环锡和一个外环锡;另两个仅以单齿配位方式各连接一个外环锡。根据核磁共振谱信息表明分子在溶液中存在着配位互变异构体之间的快交换。我们提出振动模式的假说,认为可能是羧酸酯基氧在其平面内快速摇摆建立了动态平衡之故。     

μ3-O-{[μ-(n-Bu)2Sn(μ-FcCO2)(n-Bu)2Sn]FcCO2}二聚物的晶体结构和分子结构

标题配合物Mr=933.84,属单斜晶系,空间群P2₁/n,晶胞参数a=15.244(4)Å,b=20.895(7)Å,c=12.375(4)Å,β=97.39(3)°,Z=4,V=3909(2)ų,Dc=1.5879·cm^-3,F(000)=1872,最终偏差因子R=0.0684.该配合物分子呈中心对称,是具有Sn₂O₂中心内环的二聚体,Sn₂     

二正丁基锡水杨醛缩对氨基苯甲酸酯配合物的合成、表征及结构研究

The title complex {[ⁿBu₂Sn(2-OHC₆H₄CH=NC₆H₄COO)]₂O}₂·2H₂O was synthesized by the reaction of N-(4-carboxyphenyl)-salicylideneimine with dibutyltin(IV) oxide in 1∶1 molar ratio. The compound has been characterized by elemental analysis, IR, ¹H NMR spectra and X-ray single crystal diffraction. It crystallizes in triclinic system with space group P1. The crystal data are: a=1.242 9(2) nm, b=1.261 3(2) nm, c=1.594 9(3) nm, α=102.06(2)°, β=92.884(3)°, γ=95.939(3)°, Z=2, D_c=1.342 g·cm^-3, F(000)=1 000, V=2.425 2(7) nm³, R₁=0.041 5, wR₂=0.104 4. The compound is in centro-symmetric dimer structure mode with a four-member central endo-cyclic Sn₂O₂ unit in which the bridging oxygen atoms are tri-coordinated. All the tin atoms are five-coordinated with geometry of distorted trigonal bipyramid. CCDC:286105.     

Synthesis and Characterization of a New Symmetric Dinucleating Ligand and Its Dizinc(Ⅱ)Complex with Alkoxo and Carboxylate Bridges

<正>A novel dinuclear zinc(Ⅱ)complex[Zn_2L(μ-OAc)](PF_6)_2(CH_3OH)has been synthesized from a new symmetrical compartmental ligand HL in which the pendant arms,bearing pyridyl groups,are bridged by 1,3-diaminopropan-2-ol.X-ray crystal structure shows that the two zinc atoms reside within the adjacent ligand compartments and are bridged by the endogenous alkoxo-O from ligand and one exogenous carboxylate from acetate with a syn-syn mode.The coordination geometry of two zinc atoms is a distorted trigonal bipyramid with the pyridyl-N atoms and bridging alkoxo-O atom providing the equatorial donor set.Such coordination geometry observed in this complex is similar to that found in the dinuclear unit of phospholipase C.     

Synthesis and X-ray Powder Structures of Two Lamellar Copper Arylenebis(phosphonates)

Reaction of copper salts with 1,4-phenylenebis(phosphonic acid) yielded a conventional layered compound, Cu(2)[(O(3)PC(6)H(4)PO(3))(H(2)O)(2)], while a similar reaction with 4,4'-biphenylenebis(phosphonic acid) resulted in a new lamellar structure with composition Cu[HO(3)P(C(6)H(4))(2)PO(3)H]. The structures of these compounds were solved ab initio by using X-ray powder diffraction data. The crystals of the phenylenebis(phosphonate) compound are monoclinic, space group C2/c, with a = 18.8892(4) ?, b = 7.6222(2) ?, c = 7.4641(2) ?, beta = 90.402(2) degrees, and Z = 4. The layer structure in this case is similar to that in copper phenylphosphonate, Cu[O(3)PC(6)H(5)]. The metal atoms display a distorted square pyramidal geometry where four of the coordination sites are occupied by the phosphonate oxygens. The remaining site is filled by an oxygen atom of the water molecule. Adjacent metal-O(3)PC layers are covalently pillared by the phenyl group of the phosphonates to create a 3-dimensional structure. Cu[HO(3)P(C(6)H(4))(2)PO(3)H] is triclinic, space group P&onemacr;, with a = 4.856(2) ?, b = 14.225(5) ?, c = 4.788(2) ?, alpha = 97.85(1) degrees, beta = 110.14(1) degrees, gamma = 89.38(1) degrees, and Z = 1. The structure in this case, ideally consists of linear chains of copper atoms. The copper atoms are bridged by centrosymmetrically related phosphonate groups utilizing two of their oxygen atoms. This binding mode leads to square planar geometry for the copper atoms. The third oxygen atom of the phosphonate is protonated and is involved in linking adjacent linear chains through hydrogen bonds. At the same time, these hydroxyl oxygens interact weakly (Cu-O = 3.14 ?) with the copper atoms of the adjacent chain. Considering these long Cu-O interactions, the geometry of the copper atom may be described as distorted square bipyramidal. As in the phenylphosphonate structure, the biphenyl groups covalently link the Cu-O(3)PC networks in the perpendicular direction.